Randomised Controlled TrialtaVNS

Transcutaneous auricular vagus nerve stimulation effects on inflammatory markers and clinical evolution of patients with COVID-19: a pilot randomized clinical trial

Uehara L, Corrêa JCF, Ritti R, Leite P, de Faria DRG, Pacheco-Barrios K, Castelo-Branco L, Fregni F, Corrêa FI

Expert Review of Medical Devices · 2022

Key finding

After treatment, significant intragroup differences were found in the CRP (p = 0.01), IL-6 (p = 0.01), and cortisol (p = 0.01) levels; however, in the comparison between the groups, only the CRP level was statistically lower for the a-taVNS (p = 0.04).

Condition
Long COVID
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
View on DOI

Cite this study

Uehara, L., Corrêa, J. C. F., Ritti, R., Leite, P., de Faria, D. R. G., Pacheco-Barrios, K., Castelo-Branco, L., Fregni, F., & Corrêa, F. I. (2022). Transcutaneous auricular vagus nerve stimulation effects on inflammatory markers and clinical evolution of patients with COVID-19: a pilot randomized clinical trial. Expert Review of Medical Devices, 19(11), 915-920. https://doi.org/10.1080/17434440.2022.2154147

Related studies in Long COVID

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.